<DOC>
	<DOCNO>NCT01787162</DOCNO>
	<brief_summary>Goal study ass frequency pulmonary hypertension patient chronic myeloproliferative disease . In patient echocardiography rest perform . In patient without musculoskeletal disease exercise test ( spiroergometry ) perform . Patients elevate SPAP rest reduce exercise capacity ( peak VO2 &lt; 65 % ) right heart catheterization ( RHC ) recommend . Also patient advance NYHA functional class ( III IV ) typical PH finding electrocardiogram advise undergo RHC . Additionally evaluation exercise capacity 6 MWD perform . This work- patient allow clinical hemodynamic evaluation .</brief_summary>
	<brief_title>Screening Pulmonary Vascular Changes Patients With Chronic Myeloproliferative Diseases</brief_title>
	<detailed_description>Previous small study clinical case suggest possible association pulmonary hypertension ( PH ) chronic myeloproliferative disorder ( CMPD ) . MPD may cause PH different mechanism : high cardiac output , asplenia , direct obstruction pulmonary artery megakaryocyte , chronic thromboembolic endothelial pulmonary hypertension ( CTEPH ) , porto-pulmonary hypertension ( POPH ) . However , exact prevalence PH group disorder know . This study design identify pulmonary vascular change describe prevalence pulmonary hypertension ( define study mean pulmonary arterial hypertension ( mPAP ) ≥25mmHg assess right-heart catheterization ( RHC ) systolic pulmonary arterial pressure ( sPAP ) ≥37mmHg ( 2.9 m/s ) assess echocardiography .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<criteria>Patients myeloproliferative disorder Written inform consent Manifest pulmonary hypertension Significant pulmonary disease Leftsided heart failure diastolic compliance dysfunction Hemodynamic relevant valvular disease Systemic arterial hypertension ( rest systolic &gt; 150 mmHg , diastolic &gt; 90 mmHg , exercise &gt; 220 mmHg ) Severe anemia Uncontrolled supraventricular ventricular arrhythmia Myocardial infarction ( within last 12 month ) Pulmonary embolism ( within last 12 month ) Recent therapy change ( within last 12 month ) Recent major surgery ( within last 12 month ) For exercise test : musculoskeletal disease may unable exercise test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Myeloproliferative disorder</keyword>
	<keyword>pulmonary hypertension</keyword>
	<keyword>pulmonary vascular disease</keyword>
</DOC>